HIGHLIGHTS
- who: Huijie Zhou et al. from the Renmin Hospital of Wuhan University, China have published the Article: Radiomics-guided checkpoint inhibitor immunotherapy for precision medicine in cancer: A review for clinicians, in the Journal: (JOURNAL)
- what: The authors focus on the exciting and innovative space of radiomics to solve the problems in immunotherapy and discuss how radiomics serves as a means to support the precision design of immunotherapy, especially in pseudoprogression and hyperprogression.
- how: The signature combining eight radiomics features was developed from CT images genomic data and ribonucleic_acid (RNA) sequencing. The authors . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.